ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.58
-0.50%
US Tech 100
18,387.60
0.38%
S&P 500
5,306.04
0.02%
US Dollar vs CAD
1.36547
0.05%
Bitcoin
68,372.37
0.12%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ABIOMED Inc (ABMD)

  7. ABIOMED Inc (ABMD) News

ABMD

ABIOMED (ABMD)

ABIOMED Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABMD
DateTimeSourceHeadlineSymbolCompany
01/06/20235:40AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ABMDABIOMED Inc
01/03/20237:31AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ABMDABIOMED Inc
12/27/20224:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABMDABIOMED Inc
12/27/20224:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABMDABIOMED Inc
12/27/20224:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABMDABIOMED Inc
12/27/20224:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABMDABIOMED Inc
12/27/20224:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABMDABIOMED Inc
12/22/20223:47PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:46PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:46PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:41PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:41PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:40PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:39PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:39PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:38PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:38PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:37PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:35PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:34PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
12/22/20223:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABMDABIOMED Inc
12/22/20228:15AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ABMDABIOMED Inc
12/22/20228:01AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ABMDABIOMED Inc
12/22/20227:51AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ABMDABIOMED Inc
12/21/20224:33PMBusiness WireLa FDA approuve la pompe cardiaque Impella ECP et les premiers patients sont recrutés dans un essai clinique pivotNASDAQ:ABMDABIOMED Inc
12/21/20224:13PMBusiness WireImpella ECP-Herzpumpe erhält FDA-Zulassung – erste Patienten in zulassungsrelevante klinische Studie aufgenommenNASDAQ:ABMDABIOMED Inc
12/21/20228:00AMBusiness WireFDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical TrialNASDAQ:ABMDABIOMED Inc
12/20/20223:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABMDABIOMED Inc
12/20/20223:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABMDABIOMED Inc
12/19/20225:35PMPR Newswire (US)Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400NASDAQ:ABMDABIOMED Inc
 Showing the most relevant articles for your search:NASDAQ:ABMD

Your Recent History

USOTC
CYDY
CytoDyn (QB)
USOTC
EPAZ
Epazz (PK)
USOTC
ACRL
Atacama Resources (PK)
USOTC
SAPX
Seven Arts Entertainment (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
MWWC
Marketing Worldwide (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
HHSE
Hannover House (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
FFIE
Faraday Future Intellige...
NASDAQ
TSLA
Tesla
NASDAQ
FCEL
FuelCell Energy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved